E. Philpot

发表

Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review

T. Maher, O. Distler, A. Hoffmann-Vold, 2021, ERJ Open Research.

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements.

B. Griffiths, M. Kreuter, T. Maher, 2020, The Lancet. Rheumatology.

Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis

J. Maspero, A. Finn, A. Rosenblut, 2008, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.

F. Hampel, C. Andrews, B. Prillaman, 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.

P. Dorinsky, S. Yancey, J. Stauffer, 2005, Chest.

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.

P. Ratner, W. Howland, C. Baidoo, 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.

E. Meltzer, C. Andrews, B. Prillaman, 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Effectiveness of fluticasone furoate 110 μg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen*

R. Jacobs, F. Hampel, A. Ellsworth, 2009, Current medical research and opinion.

Safety and Tolerability of Fluticasone Furoate Nasal Spray Once Daily in Paediatric Patients Aged 6–11 Years with Allergic Rhinitis

E. Meltzer, J. Maspero, Wei Wu, 2009, Clinical drug investigation.

Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis.

R. Naclerio, J. Given, H. Kaiser, 2007, The Journal of allergy and clinical immunology.

Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents.

Wei Wu, F. Hampel, P. Ratner, 2007, Allergy and asthma proceedings.

Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis

F. Hampel, C. Baidoo, K. Rickard, 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.

B. Prillaman, K. Sheth, K. Rickard, 2004, Allergy and asthma proceedings.

The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis.

K. Rickard, E. Philpot, R. Westlund, 2003, Allergy and asthma proceedings.

Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn).

R. Nathan, H. Kaiser, M. Dykewicz, 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients.

K. Blake, B. Prillaman, S. Galant, 2003, Pediatrics.

No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year.

E. Meltzer, R. Lemanske, D. Allen, 2002, Allergy and asthma proceedings.

Efficacy and safety of once‐daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk

E. Meltzer, A. Ellsworth, E. Philpot, 2009, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

HPA axis safety of fluticasone furoate nasal spray once daily in children with perennial allergic rhinitis

Wei Wu, P. Ratner, A. Levy, 2009, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Fluticasone furoate nasal spray: effective monotherapy for symptoms of perennial allergic rhinitis in adults/adolescents.

E. Meltzer, J. Douglass, Wei Wu, 2008, Allergy and asthma proceedings.

Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis.

William H. Yang, Wei Wu, R. Nathan, 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Fluticasone Furoate Nasal Spray is Effective and Well Tolerated for Perennial Allergic Rhinitis in Adolescents and Adults

N. Snowise, J. Given, A. Stillerman, 2010, American journal of rhinology & allergy.

Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment.

P. Lieberman, R. Jacobs, N. Locantore, 2009, Allergy and asthma proceedings.

Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray.

P. Ratner, Wei Wu, M. Faris, 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Relief of sinus pain and pressure with fluticasone propionate aqueous nasal spray: a placebo-controlled trial in patients with allergic rhinitis.

R. Jacobs, P. Ratner, W. Howland, 2002, Allergy and asthma proceedings.

Lack of Effect on Hypothalamic-Pituitary-Adrenal (HPA) Axis Function by Once-daily Fluticasone Furoate∗ Nasal Spray (FFNS) 110 mcg in Adolescents and Adults with Perennial Allergic Rhinitis (PAR) ∗USAN approved name

M. Faris, E. Philpot, R. Sterling, 2007 .

An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis.

W. Fokkens, R. Naclerio, Wei Wu, 2010, Allergy and asthma proceedings.

Safety of second generation antihistamines.

E. Philpot, 2000, Allergy and asthma proceedings.

A study to determine the impact of rhinitis on sufferers' sleep and daily routine

M. Blaiss, T. Reigel, E. Philpot, 2005 .

Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy.

Anand A. Dalal, J. Bernstein, Laurie A. Lee, 2009, Allergy and asthma proceedings.